Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, May 26, 2023.
Medtronic, as a leading medical device company, plays a significant role in the industry, and its stock performance is closely watched by investors and industry experts. The recent dip in Medtronic’s stock can be attributed to the company’s growth projections falling short of market expectations. Fast Five hosts Sean Whooley and Danielle Kirsh outline the company’s performance in the last quarter and what it anticipates for the future.
HeartBeam’s win of an AI-related patent for its handheld vector ECG (electrocardiogram) device highlights the company’s commitment to innovation and technological advancements in cardiac care. Whooley explains how the technology works and what’s ahead for HeartBeam.
The FDA’s approval of Zoll therapy for sleep apnea patients undergoing MRI scans is a significant development in the field of sleep medicine. The approval of Zoll therapy specifically for patients requiring MRI scans ensures that individuals with sleep apnea can undergo necessary imaging procedures without disrupting their treatment. The Fast Five hosts discuss how the technology works and the impact this will have on patients.
Boston Scientific’s decision not to acquire a majority stake in M.I. Tech signals a strategic move for the company and highlights the complexities involved in business collaborations and acquisitions. Whooley provides the details of the original transaction terms and what caused the company to bow out, along with commentary from the Federal Trade Commission.
Medtronic’s planned acquisition of EOFlow, a wearable insulin patch maker, for a substantial sum of $738 million highlights the growing interest in innovative solutions for diabetes management. This acquisition demonstrates Medtronic’s strategic focus on expanding its portfolio of diabetes care products and its commitment to providing patients with more convenient and personalized treatment options. Kirsh and Whooley discuss the purchase and how successful Medtronic Diabetes has been recently.
Subscribe to the Fast Five daily news podcast on your preferred listening platform. If you’re on a desktop computer, scan the QR code below with your smartphone to easily access the podcast on your mobile device.
Listen to previous episodes here.